A $2.5 billion pledge makes women's health a priority in Gates Foundation spend-down
Those are just two potential breakthroughs out of more than 40 the Gates Foundation intends to support through a five-year, $2.5 billion commitment on women's health research and development, more than triple the amount it has spent on women's health innovation over the past five years.
'Many of the most pressing conditions impacting women still remain understudied, underdiagnosed, and overlooked,' said Ru-fong Joanne Cheng, director of Women's Health Innovations at Gates.
A very small share of medical research funding supports the study of health specific to women, including gynecological and menstrual health, obstetric care, contraceptive innovation, sexually transmitted infections, and maternal health and nutrition, the foundation said. It cited a 2021 McKinsey and Company study that found 1% of all medical research, setting aside cancer research, goes toward women's health.
The foundation framed the commitment as part of its May announcement that it would spend down its assets over the next 20 years and concentrate much of its support on global health. While much of the research funded over the next five years will benefit women worldwide, the foundation said, the need is most acute in sub-Saharan Africa and Southeast Asia.
By devoting billions to women's health, the foundation has signaled it intends to continue to invest in the cause following the 2024 departure of Melinda French Gates, who led the foundation's support of girls' and women's health. Since her divorce from Bill Gates, French Gates has committed more than $1 billion to improve women's physical and mental health, provide more economic opportunity to women, and increase their political sway.
The announcement follows a U.S. pullback of support for global maternal health programs during the first seven months of the Trump administration.
The shuttering of the U.S. Agency for International Development and program reductions at the Centers for Disease Control have sunset programs focused on women's health. According to a March internal USAID memo, the agency's closure will stop services for 16.8 million pregnant women annually.
In April, the World Health Organization said that the 40 percent decline in maternal deaths from 2000 to 2023 has been put at risk because of aid cuts.
While the foundation continues to focus on the delivery of health care globally in an era of governmental retreat, the $2.5 billion will focus squarely on research needed to save lives, Anita Zaidi, president of Gates's Gender Equality Division, said on a press call Monday to discuss the announcement.
'This is an innovation-focused announcement,' she said. 'We need both innovation and delivery.'
It's important to remember that the U.S. Food and Drug Administration has only been required to test novel drugs on women in clinical trials since 1993, and many tests are still only done on men, said Katy Brodsky Falco, founder of the Foundation for Women's Health, which plans to make $5 million in research grants this year.
With Gates getting behind research and development of women's health with such a large commitment, others may follow, Brodsky Falco said.
'Hopefully it will bring the issue to the top of the conversation among private donors and family foundations, even if they otherwise haven't supported this type of work,' she said.
Moses Obimbo Madadi, professor at the University of Nairobi, noted that postpartum hemorrhaging causes about 3,000 deaths annually in Kenya. If men were the victims, he said, a G7 conference would be called to find a solution, but research on the subject has largely been ignored because it claims the lives of women.
'We've treated this as a peripheral issue other than making it a centerpiece of our research,' he said, calling the Gates commitment a 'very good starting point.'
_____
Alex Daniels is a senior reporter at the Chronicle of Philanthropy, where you can read the full article . This article was provided to The Associated Press by the Chronicle of Philanthropy as part of a partnership to cover philanthropy and nonprofits supported by the Lilly Endowment. The Chronicle is solely responsible for the content. For all of AP's philanthropy coverage, visit https://apnews.com/hub/philanthropy .
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
an hour ago
- Medscape
The One Crucial Question to Ask Your Eczema Patient
One of the most harmful eczema symptoms isn't visible in the clinic — it's the sleep patients lose from itching, pain, and bleeding at night. About 43% of people with eczema have sleep problems, according to a recent study review in Archives of Dermatological Research . 'If I had only one question to ask, that's the one I would choose — how's the sleep?' said Peter Lio, MD, clinical assistant professor of dermatology and pediatrics at Feinberg School of Medicine, Northwestern Medicine, Chicago. Here's why assessing sleep is crucial in eczema — and how to help patients rest better at night. Why Sleep Should Be a Standard Part of Eczema Care 'People feel very alone in this, but almost everybody reports their itch is worse at night,' said Lio. Preliminary research suggests that circadian rhythms in skin barrier function could partially explain this phenomenon. Another factor: When patients lie down to sleep, the day's responsibilities done, they may finally notice their underlying itchiness. 'People describe it like the flood gates opening,' said Zelma Chiesa Fuxench, MD, MSCE, associate professor in dermatology at Perelman School of Medicine at the University of Pennsylvania, Philadelphia. 'All of a sudden, they're not thinking about anything else that they need to do to get through the day, and the itching is there.' Some patients have insomnia — tossing, turning, and scratching for hours before falling asleep. Others 'fall asleep great but then wake up multiple times or wake up early, kind of miserable and itchy,' said Lio. Then it's hard to fall back asleep. Some people scratch while sleeping, reducing sleep quality. They don't feel rested despite going to bed and rising at normal times. 'Oftentimes their skin looks terrible in the morning, and sometimes there's even blood on the sheets,' said Lio. People with severe eczema tend to have more sleep trouble. Research suggests that tissue damage and inflammation might cause sleep disturbances, and skin barrier disruption might alter circadian rhythms and increase sensitivity to environmental triggers. What's more, insufficient sleep can directly harm skin. 'There are studies that show just keeping people up for one night, screwing up one night of sleep, has a measurable damaging effect on the skin barrier in healthy patients,' said Lio. 'So imagine if you already have a damaged barrier and are staying up night after night. You're really in a vicious loop.' In eczema sufferers, sleep problems can reduce quality of life and can be linked with depression, anxiety symptoms, and neurocognitive deficits. 'Understanding the impact of sleep loss is very important because of the association between lack of sleep and disease morbidity,' said Chiesa Fuxench. Of course, poor sleep can harm patients' overall health too. Bad sleep can also become a household problem that affects parents, caregivers, and partners of people with eczema, said Chiesa Fuxench. What to Ask Eczema Patients About Sleep Questions about sleep can give you a glimpse into a patient's day-to-day eczema control, beyond what you can see during an appointment. 'With a very dynamic disease on the skin, we have what I'll call the 'mechanic's problem,'' said Lio. That's the phenomenon of your car's funny noise disappearing when you take it to the shop. 'People will come in looking pretty good that day, so your clinical exam might not be that impressive,' he said. You might not think the patient needs treatment adjustment until you learn about their sleep habits. And patients might not volunteer this information — you have to ask, said Chiesa Fuxench. Here's how: Use a validated screening tool. Ask patients to complete a quick questionnaire with a sleep-related question before their exam. The six-question Atopic Dermatitis Control Tool asks: Over the last week, how many nights did you have trouble falling or staying asleep because of your eczema? The seven-question Patient Oriented Eczema Measure asks: Over the last week, on how many nights has your sleep been disturbed because of the eczema?When patients circle their answer, they receive a numerical score you can track over time, from zero (no problem sleeping) to four (problems every night).It's helpful to capture seven nights. If you ask patients about sleep without specifying a time frame, they might only recall the night before. Their answer might not reflect their overall sleep patterns. 'If a patient says, 'You know what, my eczema has been keeping me awake every day for the last week,' then that, to me, it's a huge exclamation point,' said Chiesa Fuxench. Ask patients to complete a quick questionnaire with a sleep-related question before their exam. The six-question Atopic Dermatitis Control Tool asks: Over the last week, how many nights did you have trouble falling or staying asleep because of your eczema? The seven-question Patient Oriented Eczema Measure asks: Over the last week, on how many nights has your sleep been disturbed because of the eczema?When patients circle their answer, they receive a numerical score you can track over time, from zero (no problem sleeping) to four (problems every night).It's helpful to capture seven nights. If you ask patients about sleep without specifying a time frame, they might only recall the night before. Their answer might not reflect their overall sleep patterns. Ask a broad question. If you can't use a screening tool, kickstart the conversation with a question that widely connects eczema and sleep. Chiesa Fuxench often asks: Are you having trouble sleeping, or is eczema affecting your sleep in any way? 'What I did for many years was simply ask: How are you sleeping? Is it affecting your sleep? Do you find that you're sleeping OK?' said Lio. 'That's probably sufficient for getting a good sense of what's going on.' How to Help People With Eczema Sleep Better When eczema disturbs a patient's sleep, Lio doesn't recommend sleep medications or sedating first-generation antihistamines as first-line treatments. They don't fix the underlying problem and can cause dependency. Focus instead on the person's skin. 'My goal is to get their skin better, to get the itch under control so that they can sleep,' he said. 'I want sleep to actually be a good measure of how we're doing.' If the patient is new or treatment-naive, consider starting treatment. Otherwise, consider advancing them to the next step of the therapeutic ladder. 'If it's a patient who was already on therapy and they're still having trouble sleeping, then it's an opportunity for us to go back and reassess: What is happening here that you are having trouble sleeping? Is it that the medication tackles some things but not others? Do we need to reassess therapy? Do we need to be more aggressive with treatment?' said Chiesa Fuxench. For example, if gentle cleansing and moisturizing aren't enough, consider topical therapy. If topicals aren't doing the trick, now might be the time to try systemic therapy or phototherapy, said Lio. 'This doesn't necessarily mean they need a certain kind of drug,' said Lio. 'It just means we need to do something different. We need to escalate therapy.' Complementary therapies such as acupuncture and hypnotherapy also help some eczema patients reduce stress and sleep better, he said. Standard sleep hygiene also applies, and a few eczema-specific bedtime habits may help: Keep pets out of bed to reduce skin irritation from dander. Ask your partner to give you a calming massage at night to relax before sleep. Use silk sheets to reduce friction. Wash your bedding every 1-2 days to remove dust mites. Use fragrance-free detergent and run the rinse cycle twice to remove soap residue. Forgot to wash your sheets? Keep an ultraviolet C sanitizing wand nearby and run it over your bedding to kill dust mites. Use an air purifier in your bedroom to remove dander and other irritants. As you follow up with the patient, watch for other signs of sleep-sabotaging health problems. Ask: Are you having trouble functioning? The patient might need a referral to a mental health care provider or another specialist. 'Patients with atopic dermatitis may also have other reasons why they're having trouble sleeping,' said Chiesa Fuxench. 'We are physicians at the end of the day, and we have to look at the patient as this entire being, not just someone who has atopic dermatitis.' Lio has consulted or advised for AbbVie Inc., Apogee Therapeutics Inc., Arcutis Biotherapeutics, Eli Lilly and Company, Galderma, Incyte Corporation, L'Oreal, Pfizer Inc., Regeneron Pharmaceuticals Inc., and Sanofi-Aventis US LLC, Skinfix Inc.; and Verrica Pharmaceuticals Inc. He has ownership or investment interest in Alphyn Biologics Inc., Boston Skin Science LLC, Codex Labs, Concerto Biosciences, LearnHealth Inc., Medable Inc., Modernizing Medicine Inc., Soteri Skin, Stratum Biosciences, Thimble Health LLC, Verdant Scientific Inc., Yobee Care Inc. He has the right to receive payments or may receive future financial benefits for inventions or discoveries related to Theraplex.
Yahoo
an hour ago
- Yahoo
Vanguard Health Care Fund's Strategic Moves: Johnson & Johnson Takes Center Stage with 2. ...
Exploring the Latest Investment Strategies of Vanguard Health Care Fund (Trades, Portfolio) Vanguard Health Care Fund (Trades, Portfolio) recently submitted its N-PORT filing for the second quarter of 2025, shedding light on its strategic investment decisions during this period. Managed by Jean M. Hynes, CFA, CEO of Wellington Management Company, the fund is renowned for its focus on long-term capital appreciation within the health care sector. Wellington Management Company, established in 1928, is one of the oldest and most respected institutional investment managers in the United States, advising the Vanguard Health Care Fund (Trades, Portfolio) since 1984. The fund aims to maintain a diversified exposure across five primary subsectors: health services, medical products, specialty pharmaceuticals, major pharmaceuticals, and international markets. Its investment philosophy emphasizes companies with robust balance sheets, strong management, and potential for innovative products that could drive above-average growth in revenue and earnings. The fund's contrarian style often leads to purchasing stocks after negative events have caused a decline in share price. Summary of New Buy Vanguard Health Care Fund (Trades, Portfolio) added a total of eight stocks, with the most significant addition being Johnson & Johnson (NYSE:JNJ). The fund acquired 4,660,244 shares, which now account for 2.05% of the portfolio, with a total value of $711.85 million. The second largest addition was Roche Holding AG (XSWX:ROG), consisting of 1,677,044 shares, representing approximately 1.58% of the portfolio, with a total value of CHF 547,420,130. The third largest addition was Gilead Sciences Inc (NASDAQ:GILD), with 4,823,087 shares, accounting for 1.54% of the portfolio and a total value of $534.74 million. Key Position Increases Vanguard Health Care Fund (Trades, Portfolio) also increased stakes in a total of 16 stocks. The most notable increase was in Elevance Health Inc (NYSE:ELV), with an additional 507,005 shares, bringing the total to 1,700,286 shares. This adjustment represents a significant 42.49% increase in share count, a 0.57% impact on the current portfolio, with a total value of $661.34 million. The second largest increase was in Cencora Inc (NYSE:COR), with an additional 501,886 shares, bringing the total to 2,279,215. This adjustment represents a significant 28.24% increase in share count, with a total value of $683.42 million. Summary of Sold Out Vanguard Health Care Fund (Trades, Portfolio) completely exited 12 holdings in the second quarter of 2025. Notable exits include Blueprint Medicines Corp (BPMC), where the fund sold all 1,362,970 shares, resulting in a -0.32% impact on the portfolio. Another significant exit was Surgery Partners Inc (NASDAQ:SGRY), with the liquidation of all 4,602,252 shares, causing a -0.29% impact on the portfolio. Key Position Reduces Vanguard Health Care Fund (Trades, Portfolio) also reduced its position in 45 stocks. The most significant changes include a reduction in Novartis AG (XSWX:NOVN) by 5,691,220 shares, resulting in a -49.44% decrease in shares and a -1.66% impact on the portfolio. The stock traded at an average price of CHF 93.19 during the quarter and has returned 8.24% over the past three months and 13.88% year-to-date. Another notable reduction was in Edwards Lifesciences Corp (NYSE:EW) by 6,663,224 shares, resulting in a -37.32% reduction in shares and a -1.27% impact on the portfolio. The stock traded at an average price of $74.55 during the quarter and has returned 2.89% over the past three months and 4.93% year-to-date. Portfolio Overview As of the second quarter of 2025, Vanguard Health Care Fund (Trades, Portfolio)'s portfolio included 81 stocks. The top holdings included 10.78% in Eli Lilly and Co (NYSE:LLY), 6.49% in AstraZeneca PLC (LSE:AZN), 5.56% in UnitedHealth Group Inc (NYSE:UNH), 4.52% in Merck & Co Inc (NYSE:MRK), and 4.35% in Boston Scientific Corp (NYSE:BSX). The holdings are mainly concentrated in one of the 11 industries: Healthcare. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus.
Washington Post
an hour ago
- Washington Post
Yes, these rabbits appear to have tentacles. They're harmless, experts say.
Rabbits with tentacle-like growths emerging from their heads were spotted in Colorado this past week and photos were shared widely on social media, but officials said there was little cause for alarm. Kara Van Hoose, spokesperson for Colorado Parks and Wildlife, said the growths were likely the result of a papillomavirus that could not spread to humans or other animal species and was not new to the region.
